Cited by 22Gastric Cancer Management and OutcomesInflammatory mediators and NSAID effectsCancer, Stress, Anesthesia, and Immune Response

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Antidepressants and Gastric Cancer: A Nationwide Population-Based Nested Case-Control Study

Open access

Abstract

BACKGROUND: To our knowledge, no epidemiological study has reported on whether an association between antidepressant exposure and gastric cancer exists. Herein, we aim to investigate the possible association between antidepressant exposure and gastric cancer incidence. METHODS: Using a nested case-control design, we identified 26289 cases with gastric cancer and 127984 controls from Taiwan's National Health Insurance Research Database (NHIRD). The data were analyzed using a conditional logistic regression model adjusting for possible confounding variables. RESULTS: We found antidepressant use did not increase the risk of gastric cancer. The lack of an association between antidepressant prescription and elevated gastric cancer incidence was apparent for across selective serotonin-reuptake inhibitors (SSRIs), tricyclic agents (TCAs), serotonin-norepinephrine reuptake inhibitors (SNRIs), reversible inhibitors of monoamine oxidase A (RIMA), trazodone, mirtazapine and bupropion. There were slightly decreased gastric cancer risks of SSRIs use (≧28 DDD group, adjusted OR = 0.87; 95% CI = 0.78-0.96). Sensitive analysis showed SSRIs, TCAs, and SNRIs did not increase gastric cancer risks significantly even in the group with peptic ulcer history. CONCLUSIONS: An association between antidepressant exposure and gastric cancer was not apparent in this analysis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0143668

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The 30-day criterion for antidepressant users is widely accepted in other studies.

    “and this criterion is widely accepted in other studies [40-42].”

    From Risk analysis of use of different classes of antidepressants on subsequent dementia: A nationwide cohort study in Taiwan (2017) · cites this paper as [42]

    The Materials and Methods section (Antidepressants’ exposure; page not provided) uses a threshold of at least 28 defined daily doses, which is close to—but not the same as—a 30-day criterion. It does not say that a 30-day criterion for antidepressant users is widely accepted in other studies. (LLM, conf=0.78)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 19

  1. A Jemal, 2011, Global cancer statistics, CA: a cancer journal for clinicians, 61, 69
  2. LE Hansson, 1996, The risk of stomach cancer in patients with gastric or duodenal ulcer disease, The New England journal of medicine, 335, 242, 10.1056/NEJM199607253350404 · DOI
  3. CY Wu, 2010, Effective reduction of gastric cancer risk with regular use of nonsteroidal anti-inflammatory drugs in Helicobacter pylori-infected patients, Journal of clinical oncology: official journal of the American Society of Clinical Oncology, 28, 2952, 10.1200/JCO.2009.26.0695 · DOI
  4. H Dursun, 2009, Antiulcer activity of fluvoxamine in rats and its effect on oxidant and antioxidant parameters in stomach tissue, BMC gastroenterology, 9, 36, 10.1186/1471-230X-9-36 · DOI
  5. H Suleyman, 2009, Comparative study on the gastroprotective potential of some antidepressants in indomethacin-induced ulcer in rats, Chemico-biological interactions, 180, 318, 10.1016/j.cbi.2009.03.002 · DOI
  6. T Takahashi, 2012, Therapeutic effect of paroxetine on stress-induced gastric lesions in mice, Progress in neuro-psychopharmacology & biological psychiatry, 36, 39, 10.1016/j.pnpbp.2011.08.017 · DOI
  7. KA Abdel-Sater, 2012, The gender difference of selective serotonin reuptake inhibitor, fluoxetine in adult rats with stress-induced gastric ulcer, European journal of pharmacology, 688, 42, 10.1016/j.ejphar.2012.04.019 · DOI
  8. CX Ji, 2012, Evaluation of the anti-ulcerogenic activity of the antidepressants duloxetine, amitriptyline, fluoxetine and mirtazapine in different models of experimental gastric ulcer in rats, European journal of pharmacology, 691, 46
  9. K Takeuchi, 2011, Aggravation by paroxetine, a selective serotonin reuptake inhibitor, of antral lesions generated by nonsteroidal anti-inflammatory drugs in rats, The Journal of pharmacology and experimental therapeutics, 338, 850, 10.1124/jpet.111.183293 · DOI
  10. C Andrade, 2010, Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms, The Journal of clinical psychiatry, 71, 1565, 10.4088/JCP.09r05786blu · DOI
  11. SO Dalton, 2003, Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study, Archives of internal medicine, 163, 59, 10.1001/archinte.163.1.59 · DOI · Paper page
  12. YP Wang, 2014, Short-term use of serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding, The American journal of psychiatry, 171, 54, 10.1176/appi.ajp.2013.12111467 · DOI
  13. SO Dalton, 2000, Antidepressant medications and risk for cancer, Epidemiology, 11, 171, 10.1097/00001648-200003000-00015 · DOI
  14. TL Vaughan, 1998, Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux, Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 7, 749
  15. J Haukka, 2010, Incidence of cancer and antidepressant medication: record linkage study, International journal of cancer Journal international du cancer, 126, 285, 10.1002/ijc.24537 · DOI
  16. M Bilici, 2012, Effect of mirtazapine on MNNG-induced gastric adenocarcinoma in rats, Asian Pacific journal of cancer prevention: APJCP, 13, 4897, 10.7314/APJCP.2012.13.10.4897 · DOI
  17. S Wacholder, 1992, Selection of controls in case-control studies. III. Design options, American journal of epidemiology, 135, 1042, 10.1093/oxfordjournals.aje.a116398 · DOI
  18. KJ Rothman, 1981, Induction and latent periods, American journal of epidemiology, 114, 253, 10.1093/oxfordjournals.aje.a113189 · DOI
  19. I Tramacere, 2012, A meta-analysis on alcohol drinking and gastric cancer risk, Annals of oncology: official journal of the European Society for Medical Oncology / ESMO, 23, 28, 10.1093/annonc/mdr135 · DOI

Cited by

Sorted by citations

Metadata

Authors
Hsieh, Y.-H., Chiu, W.-C., Lin, C.-F., Chan, H.-L., Liang, H.-Y., Lee, Y., McIntyre, R. S., & Chen, V. C.-H.
Affiliations
  • Linkou Chang Gung Memorial Hospital (TW)
  • Fu Jen Catholic University (TW)
  • University Health Network (CA)
  • Chiayi Chang Gung Memorial Hospital (TW)
Corresponding author
Chen, Vincent Chin-Hung
Venue
PLOS ONE
Published
2015-11-25
Volume
10
Issue
11
Pages
e0143668
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2176174885
Cited by
22
References
1
Citations by year
2025: 2 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 5 · 2019: 1 · 2018: 6 · 2017: 3 · 2016: 1
FWCI
1.50
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
  • Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
Keywords
antidepressants, gastric cancer, gastric cancer incidence, selective serotonin reuptake inhibitors, tricyclic antidepressants, serotonin-norepinephrine reuptake inhibitors, trazodone, mirtazapine, bupropion, peptic ulcer
MeSH terms
Adult, Aged, Aged, 80 and over, Antidepressive Agents, Female, Humans, Male, Middle Aged, Population Surveillance, Risk, Socioeconomic Factors, Stomach Neoplasms, Taiwan, Comorbidity, Confounding Factors, Epidemiologic, Case-Control Studies, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review